Abstract
This study evaluates the impact of chemotherapy and radiotherapy on the BMI classification of cancer patients before and after the third therapy cycle. A total of 300 patients, equally divided between the two treatment groups, were analysed. At baseline, the majority of patients were classified as having a normal BMI (69.3%), while underweight and morbidly obese individuals accounted for smaller proportions.